Kyle Garland

“Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy” published in Chemical Reviews, selected as VINSE Spotlight Publication

About the authors: Co-first author, Kyle Garland earned his Ph.D. in Chemical Engineering in 2021 under the direction of Prof. John Wilson and is currently working for Brooklyn Immunotherapeutics, Inc. in San Diego, California as an R&D scientist investigating in vivo gene editing. His dissertation focused on the… Read More

Jul. 21, 2022